Navigation Links
Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance
Date:12/11/2008

ions with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. More information about Lilly is available at www.lilly.com. C-LLY

This press release contains forward-looking statements that are based on management's current expectations, but actual results may differ materially due to various factors. There are significant risks and uncertainties in pharmaceutical research and development. There can be no guarantees with respect to pipeline products that the products will receive the necessary clinical and manufacturing regulatory approvals or that they will prove to be commercially successful. The company's results may also be affected by such factors as competitive developments affecting current products; rate of sales growth of recently launched products; the timing of anticipated regulatory approvals and launches of new products; other regulatory developments and government investigations; patent disputes and other litigation involving current and future products; the impact of governmental actions regarding pricing, importation, and reimbursement for pharmaceuticals; changes in tax law; asset impairments and restructuring charges and the impact of exchange rates. For additional information about the factors that affect the company's business, please see the company's latest Form 10-K, filed March 2008, and Form 10-Q filed November 2008. The company undertakes no duty to update forward-looking statements.

    Alimta(R) (pemetrexed, Lilly)
    Byetta(R) (exenatide injection, Amylin Pharmaceuticals)
    Cialis(R) (tadalafil, Lilly)
    Comfortis(TM) (Lilly)
    Cymbalta(R) (duloxetine hydrochloride, Lilly)
    Erbitux(R) (cetuximab, ImClone Systems, Lilly)
    Gemzar(R) (gemcitabine hydrochloride, Lilly)
    Humalog(R) (insulin lis
'/>"/>
SOURCE  Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 

Related biology technology :

1. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
2. Lilly Declares Fourth-Quarter Dividend
3. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
4. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
5. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
6. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
7. Lilly Announces Termination of AIR Insulin Program
8. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
9. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
10. Lilly Reports Solid First-Quarter Results
11. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... conducted pursuant to Special Protocol Assessment with ... CITY, Dec. 16 /PRNewswire-FirstCall/ - AEterna Zentaris ... (the "Company"), a global biopharmaceutical company focused ... the initiation, by its partner Keryx Biopharmaceuticals ... 3 registration clinical trial for perifosine (KRX-0401), ...
(Date:12/16/2009)... The American Filtration and Separations Society will hold its 23rd Annual ... Hyatt Hotel in San Antonio, Texas. To further impact the separation ... we are proud to announce that the 2010 AFS Annual Technical ... , , ... Minneapolis, MN (PRWEB) December 16, 2009 ...
(Date:12/15/2009)... Sky One,Medical, Inc. ("China Sky One Medical" or ... integrated pharmaceutical company developing and producing,over-the-counter drugs in ... the Company has 30 medicines that will be ... Medical Insurance, Industrial Injury Insurance,and Maternity Insurance Medicine ... medicines treat a variety of common ailments and ...
(Date:12/15/2009)... for Atomic Force Microscopy (AFM) have been developed and are ... the liquid/air interface. The NeedleProbes’ cylindrical geometry enables researchers ... and viscosity - all in a single force distance curve. ... ... -- New, constant diameter NeedleProbes are enabling unique ...
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3
... LOTS: 107054, 117085, 047056, 097081, 107024, 107064, 107066, 107074, ... ... 25 Baxter Healthcare,Corporation has announced the voluntary recall of nine lots ... recalling the lots on January 17, 2008 as a precautionary measure due,to ...
... 25 /PRNewswire-FirstCall/ - ARIUS Research Inc., (TSX:,ARI), a biotechnology company discovering and ... conference call to,discuss its fourth quarter and year end 2007 results at ... its results in,a press release to be issued at 7:00 a.m. prior ... Tuesday, January 29, 2008, ...
... and Chief Science & Technology Officer Uma Chowdhry offered,her ... of global,policy during a discussion at the World Economic ... to inform the policymaking process, to help,understand both benefits ... is,knowable, and what is possible," Chowdhry said. "Future progress ...
Other Biology Technology:Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials 2ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call 2DuPont Chief Science & Technology Officer Offers Perspectives on Science and Global Policymaking at Davos World Economic Forum 2DuPont Chief Science & Technology Officer Offers Perspectives on Science and Global Policymaking at Davos World Economic Forum 3
(Date:12/15/2009)... The 2009 Frost & Sullivan European Border ... Sagem Securite (Safran Group) for its innovative ... the company,s expertise in advanced biometric technology ... value-added products to end users. ,, ... Securite has been involved in delivering identification ...
(Date:12/15/2009)... Clinical Laboratory, San Diego, California, has been awarded ... (CAP), based on results of a recent onsite ... advised of this national recognition and congratulated for ... Biotech Inc. GenWay Clinical Laboratory is one of ... Laboratory Accreditation Program, begun in the early 1960s, ...
(Date:12/15/2009)... is available in German . , Leipzig: ... predicting the future distribution of mammals. This is the ... 140 indigenous European mammals. The researchers analysed data on ... as the phylogenetic information of the species. Judging by ... related species, mammals seem to adapt fast to changing ...
Breaking Biology News(10 mins):Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 4Species distribution models are of only limited value for predicting future mammal distributions 2UBC researchers find key microbial indicator of ocean health 10508 1UBC researchers find key microbial indicator of ocean health 10508 2Penn study 3A Transforming nanowires into nano tools using cation exchange reactions 14572 1Penn study 3A Transforming nanowires into nano tools using cation exchange reactions 14572 2Penn study 3A Transforming nanowires into nano tools using cation exchange reactions 14572 3Scientists Zero in on Brains Stopwatch 60001 1
... Finger Activated Mailboxes, Roll-a-Board Luggage, Among Products Expected ... to be Available to Consumers ... (OTC,Bulletin Board: BMRX) a leading developer of biometrically secured consumer,products, ... several new smartTOUCH(TM) products for the consumer travel and,residential markets ...
... that it is launching a new journal, the Journal ... be published bimonthly, and will focus on the advances ... and engineering. The first issue will appear in late ... Engineering will cover the fields of natural gas exploration, ...
... Among humans, making yourself smell more alluring than you really ... a complete perfume industry. However, it is a matter of ... dupe ant workers into believing them to be one of ... Science this week , researchers from the Centre for Social ...
Other Biology News:bioMETRX to Introduce New smartTOUCH(TM) Products in 2008 2bioMETRX to Introduce New smartTOUCH(TM) Products in 2008 3Elsevier launches new journal: Journal of Natural Gas Science and Engineering 2Smell-wars between butterflies and ants 2
... is a high performance spectral scanning ... incubator. With the advanced SkanIt Software ... for drug discovery assay development. Varioskan ... intensity, time-resolved fluorescence and photometric assays ...
Strip Removal Tool 25/Box...
Oven mesh sheets, large, 23 x 23cm, pack of 5...
... Protein Phosphatase ( l-PPase) ... phosphatase with activity towards ... tyrosine residues. It is ... of the ORF221 open ...
Biology Products: